Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Syndax Pharmaceuticals (SNDX) Non-Current Deffered Revenue (2016 - 2021)

Syndax Pharmaceuticals has reported Non-Current Deffered Revenue over the past 7 years, most recently at $10.9 million for Q2 2021.

  • Quarterly results put Non-Current Deffered Revenue at $10.9 million for Q2 2021, down 12.25% from a year ago — trailing twelve months through Jun 2021 was $10.9 million (down 12.25% YoY), and the annual figure for FY2020 was $11.6 million, down 11.54%.
  • Non-Current Deffered Revenue for Q2 2021 was $10.9 million at Syndax Pharmaceuticals, down from $11.2 million in the prior quarter.
  • Over the last five years, Non-Current Deffered Revenue for SNDX hit a ceiling of $16.8 million in Q4 2017 and a floor of $10.9 million in Q2 2021.
  • Median Non-Current Deffered Revenue over the past 5 years was $13.6 million (2017), compared with a mean of $13.6 million.
  • Biggest five-year swings in Non-Current Deffered Revenue: grew 17.86% in 2017 and later dropped 12.58% in 2018.
  • Syndax Pharmaceuticals' Non-Current Deffered Revenue stood at $16.8 million in 2017, then dropped by 12.58% to $14.6 million in 2018, then decreased by 10.35% to $13.1 million in 2019, then fell by 11.54% to $11.6 million in 2020, then fell by 6.52% to $10.9 million in 2021.
  • The last three reported values for Non-Current Deffered Revenue were $10.9 million (Q2 2021), $11.2 million (Q1 2021), and $11.6 million (Q4 2020) per Business Quant data.